CEL-SCI Corporation
General ticker "CVM" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $34.8M
CEL-SCI Corporation does not follow the US Stock Market performance with the rate: -37.8%.
Estimated limits based on current volatility of 12.1%: low 0.67$, high 0.86$
Factors to consider:
- Earnings expected soon, date: 2024-12-27 bmo
- Current price 12.1% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-09-30 to 2025-09-29
- 2023-09-30 to 2024-09-29 estimated range: [0.85$, 2.22$]
- 2024-09-29 to 2025-09-29 estimated range: [0.79$, 2.04$]
Financial Metrics affecting the CVM estimates:
- Negative: Non-GAAP EPS, $ of -0.72 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -28.61 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -24.49 <= 3.85
- Positive: Inventory ratio change, % of 0 <= 1.08
- Negative: 0 < Interest expense per share, $ of 0.02
Short-term CVM quotes
Long-term CVM plot with estimates
Financial data
| YTD | 2021-09-30 | 2022-09-30 | 2023-09-30 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $36.19MM | $36.06MM | $31.48MM |
| Operating Income | $-36.19MM | $-36.06MM | $-31.48MM |
| Non-Operating Income | $0.19MM | $0.18MM | $-0.50MM |
| Interest Expense | $1.15MM | $1.08MM | $0.68MM |
| R&D Expense | $23.11MM | $25.36MM | $22.47MM |
| Income(Loss) | $-36.00MM | $-35.88MM | $-31.98MM |
| Profit(Loss) | $-36.00MM | $-35.88MM | $-31.98MM |
| Stockholders Equity | $56.53MM | $32.16MM | $13.21MM |
| Inventory | $2.01MM | $2.00MM | $2.25MM |
| Assets | $75.87MM | $50.52MM | $30.53MM |
| Operating Cash Flow | $-18.79MM | $-18.24MM | $-22.85MM |
| Capital expenditure | $9.04MM | $0.66MM | $0.37MM |
| Investing Cash Flow | $-15.18MM | $5.49MM | $-0.37MM |
| Financing Cash Flow | $54.52MM | $-0.64MM | $4.69MM |
| Earnings Per Share* | $-0.96 | $-0.89 | $-0.73 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.